The efficacy and side effects of oxytocin, methyl ergonovine (metergin) and misoprostol in the excretion of pregnancy products.

Comparison of the efficacy and side effects of oxytocin + misoprostol with methyl ergonovine (metergin) + misoprostol and misoprostol alone in the excretion of pregnancy products.

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200122046221N1

Enrollment

Registered

2020-05-11

Start date

2020-04-02

Completion date

Unknown

Last updated

2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

incomplete abortion in first trimester. Incomplete spontaneous abortion without complication

Interventions

Intervention 1: Intervention group: How to prescribe the drugs in the first intervention group: Oxytocin 1 amp (dose of amp: 10 unit) in the morning, 1 amp in the afternoon and 1 amp in the evening(I

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: tendency toward outpatient treatment gestational age less than 14 week not presence of high risk disease

Exclusion criteria

Exclusion criteria: presence of a major disease the patients who can not tolerate drugs those who get tired from the process of treatment

Design outcomes

Primary

Measure	Time frame
Time of disposal of pregnancy products. Timepoint: Before starting the study . 3-6-9 days after starting the drug regimen. Method of measurement: The time from partial abortion to complete disposal of pregnancy products was measured.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactathar rasekhjahromi

Jahrom University of Medical Sciences

drrasekh@yahoo.com+98 71 5433 1521

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 10, 2026